Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Adrenal Gland Neoplasms × Mitotane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Adrenocortical Carcinoma 5 Adrenal Gland Neoplasms 1

Interventions

pertuzumab 1 olaparib 1 lutetium Lu 177 dotatate 1 camrelizumab 1 apatinib 1 Observation 1 Nivolumab 1 Mitotane 1 Gefitinib 1 Floxuridine 1 Erlotinib Hydrochloride 1 Dexamethasone 1 Adrenalectomy 1 (18F)GTP1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06831175 2025-06-03

Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma

West China Hospital

Phase 2 Recruiting

Adrenal Gland Neoplasms, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡